cannot work anymore."
At a crisis meeting last week, the academy's leadership decided to stop paying for repairs and procurement, including purchasing scientific equipment, starting in January. If budgets continue to decline, staff may have to be laid off, says Drahoš. The reform comes from a council chaired by Jan Fischer, the Czech prime minister, and comprising representatives from universities, the academy and industry. Initially, applied and industryoriented research were supposed to be strengthened without affecting basic research. Changes included reallocating science portfolios to the industry ministry and creating a new technology agency. The government had said previously that public-science budgets would increase by 2 billion koruny per year, to 31 billion in 2012. But the economic crisis has thwarted the plan, and science expenditure is now frozen at 25 billion koruny per year.
The freeze follows several prosperous years for Czech science, which has experienced a notable upswing since the country entered the European Union (EU) in 2004: it now spends around 1.4% of its gross domestic product, up from 1.2% in 2003, on research and development. This is more than any other formerly socialist, eastern European country in the EU.
Critics say that the new system is a step backwards. "It started out as a good idea, but then it got screwed up in the hands of technocrats," says Pavel Jungwirth, a computational chemist at the Institute of Organic Chemistry and Biochemistry. Jan Zrzavý, a biologist at the University of South Bohemia in České Budějovice, who was on the government council that drafted the reform, declined to comment, saying that transferring the discussion to an international forum would be "illcalculated and potentially harmful". The consensus of the meeting was that H1N1 vaccines, which could be given to billions of people this year, should contain an adjuvant. These vaccination programmes will provide a unique opportunity to identify any extremely rare side effects, says virologist Albert Osterhaus of the University of Rotterdam, the Netherlands, as long as they have "mechanisms to monitor all cases of autoimmune disease to see if the vaccine is really to blame." Sean Morrison, a stem-cell biologist at the University of Michigan in Ann Arbor, adds: "The NIH has done what is best for the field by having their own registry -one list that everyone can work from. " Some scientists, including Daley, said that they were disappointed with the exclusion of embryos derived for research purposes, but pointed out that the agency intends to revisit the guidelines as the science evolves.
The NIH guidelines depart in one significant way from existing National Academy of Sciences standards; they do not require consent from gamete donors -only from the couple seeking in vitro fertilization services.
The 
